Interferences in quantitative immunochemical methods;Interferencije svojstvene kvantitativnim imunokemijskim metodama

Biochemia Medica

Volumn 19, Issue 1, 2009, Pages 50-62

  Dodig, Slavica ^a  

^a SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

Author keywords

Cross reactivity; immunoassays; Interferences; Prozone e9ect

Indexed keywords

CROSS REACTING ANTIBODY; CROSS REACTING ANTIGEN;

CROSS REACTION; IMMUNOASSAY; MEASUREMENT; REVIEW;

EID: 67649289985     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2009.005     Document Type: Review

References (111)

1. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36: 704-21.
2. Ismail AAA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr WA. Wrong Biochemistry Results: Two Case Reports and Observational Study in 5310 Patients on Potentially Misleading Thyroid-stimulati-ng Hormone and Gonadotropin Immunoassay Results. Clin Chem 2002;48:2023-9.
3. Marks V. False-Positive Immunoassay Results: A Multicenter Survey of Erroneous Immunoassay Results from Assays of 74 Analytes in 10 Donors from 66 Laboratories in Seven Countries. Clin Chem 2002;48: 2008-16.
4. Preiser W, Brink NS, Hayman A, WaiteJ, Balfe P, Tedder RS. False-nega-tive HIV antibody test results. J Med Virol 2000;600:43-7.
5. BohnerJ, von Pape K-W, Hannes W, Stegmann T. False-negative immu-noassay results for cardiac troponin I probably due to circulating tro-ponin I autoantibodies. Clin Chem (letter) 1996;42:2046.
6. Ismail AA. On the interpretation of acrmative follow-up tests in im-munoassays: what must not be done? Ann Clin Biochem 2006;43: 249-51.
7. McNeely M. Antibodies: the laboratory depends on them but they can let us down. Labmedicine 2002;33:873-6.
8. Cole LA, Rinne KM, Shahabi S, Omrani A. False-positive hCG assay re-sults leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem 1999;45:313-4.
9. Rotmensch S, Cole S. False diagnosis and needless therapy or presu-med malignant diseases in women with false-positive human chorio-nic gonadotropin concentrationa. Lancet 2000;355:712-5.
10. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
11. Kricka LJ. Interferences in immunoassays - still a threat. Clin Chem 2000;46:1037-8.
12. TateJ, Ward G. Interferences in Immunoassay. Clin Biochem Rev 2004; 25:105-20.
13. Emerson JF, Ngo G, Emerson SS. Screening for interference in immu-noassays. Clin Chem 2003;49:1 163-9.
14. Kricka LJ. Human anti-animal interferences in immunological assays. Clin Chem 1999;45:942-56.
15. Ismail AAA. A radical approach is needed to eliminate interferen-ces from endogenous antibodies in immunoassays. Clin Chem 2005;51:25-6.
16. Kaplan IV, Levinson SS. When is a heterophile antibody not a heterop-hile antibody? When it is an antibody against a speciPc immunogen. Clin Chem 1999;45:616-8.
17. Rigo RB, Panyella MG, Bartolomé LR, Ramos PA, Soria PR, Navarro MA. Variations observed for insulin concentrations in an interlaboratory quality program may be due to interferences between reagents and the ma trix of the control materials. Clin Biochem 2007;40:1088-91.
18. Ylander PJ, Bicskei Z, Hänninen P, SoiniJT. Theoretical assessments of errors in rapid immunoassays-how critical is the exact timing and rea-gent concentrations?Biophys Chem2006;20:141-5.
19. Saidinejad M, Law T, Ewald MB. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic an-tidepressants. Pediatrics 2007;120:e504-9.
20. Després N, Grant AM. Antibody interference in thyroid assays: a poten-tial for clinical misinformation. Clin Chem 1998;44:440-54.
21. Jones AM, Honour JW. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol 2006;64:234-44.
22. Knight AK, Bingeman T, Cole L, Cunningham-Rundles C. Frequent false positive beta human chorionic gonadotropin tests in immunoglobuli-neA dePciency. Clin Exp Immunol 2005;141 :333-7.
23. Cavalier E, CarlisiA, ChapelleJP, DelanayeP. False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin ChimActa 2008;387:150-2.
24. McCudden CR, Willis MS,Grenache DG. Persistent low concentration of human chorionic gonadotropin in a nonpregnant woman.Clin Chem 2008;54:209-14.
25. Berth M, Bosmans E, Everaert J, Dierick J, Schiettecatte J, Anckae-rt E, Delanghe J. Rheumatodic factor interference in the determi-nation of carbohydrate antigen 19-9 (CA19-9). Clin Chem Lab Med 2006;44:1137-9.
26. Melanson SE, Lee-Lewandrowski E, Griggs Da, Long WH, Flood JG. Re-duced interference by phenothiazines in amphetamine drug of abuse immunoassays. Arch Pathol Lab Med. 2006;130:1834-8.
27. Dasgupta A. Endogenous and exogenous digoxin-like immunoreacti-ve substances: impact on therapeutic drug monitoring ofdigoxin. Am J Clin Pathol 2002;118:132-40.
28. Roberts WL, De BK, Coleman JP, Annesley TM. Falsely increased immu-noassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin. Clin Chem 1999;45:829-37.
29. Panteghini M. Selection of antibodies and epitopes for cardiac tropo-nin immunoassays: Should we revise our evidence-based beliefs? Clin Chem 2005;51:803-4.
30. Lum G, Solarz DE, Farney L. False positive cardiac troponin results in pa-tients without acute myocardial infarction. Labmedicine 2006;37:546-50.
31. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative In-terference in Cardiac Troponin I Immunoassays by Circulating Tropo-nin Autoantibodies. Clin Chem 2005;51:839-47.
32. Duverlie G, Driencourt M, Roussel C, OrPla J. Heterophile IgM, IgA, and IgE antibodies in infectious mononucleosis. J Allergy Clin Immunol 2007;119:640-5.
33. Covinsky M, Laterza O, PfeiferJD, Farkas-Szallasi T, Scott MG. IgM? an-tibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem 2000;46:1157-61.
34. Wu JT. Quantitative immunoassay: A practical guide for assay estab-lishment, troubleshooting, and clinical application. AACC Press, Was-hington 2000.
35. Gosling JP. Immunoassays. A practical approach. Oxford: Oxford Uni-versity Press, 2000.
36. Nilsson C, Seppälä, Pettersson K. Immunological characterization of human luteinizing hormone with special regard to a common genetic variant. J Endocrinol 2001 ;168:107-16.
37. Andrew R. Clinical measurement of steroid metabolism. Best Practi-ce&Res Clin Endocrinol&Metabolism 2001;15:1-16.
38. Lee C, Goeger DE. Interference of 6 β-hydroxycortisol in the quantita-tion of urinary free cortisol by immunoassay and its elimination by so-lid phase extraction. ClinBiochem 1998;31:229-33.
39. Wright JL, Lange PH. Newer potential biomarkers in prostate cancer. Urology 2007;9:207-13.
40. Mari A, Iacovacci P, Aperni C, Barletta B, Tinghino R, Di Felice G, et al. SpeciPc IgE to cross-reactive carbohydrate determinants strongly af-fect the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol 1999;103:1005-11.
41. CantisaniA, Giuprida, Fabris C, Bertino E, Coscia A, Oggero R, et al. De-tection of speciPc IgE to human milk proteins in sera ofatopic infants. FEBSLett 1997;412:515-7.
42. Aalberse RC. Allergens from mites: implications of cross-reactivity be-tween invertebrate antigens. Allergy 1998;53:47-8.
43. Chou MC, Yuo CY, Lan WS, Huang SP. Seral IgE of atopic indivi-duals exhibit the reactivity to multiple allergens. J Biomed Lab Sci. 2001;13:1-5.
44. Fuchs T, SpitzauerS, Vente C, HevierJ, Kspiotis S, Rumpold H, etal. Na-tural latex, grass pollen, and weed pollen share IgE epitopes. J Allergy Clin Immunol 1997;100:356-64.
45. Adédoyin J, Johansson SGO, Grönlund H, van Hage M. Interference in immunoassays by human IgM with speciPcity for the carbohydrate moiety of animal proteins. J Immunol Methods 2006;310:117-25.
46. Hemmer W, Focke M, Kolarich D, Wilson IB, Altmann F, Wohrl S, et al. Antibody binding to venom carbohydrates is a frequent cause fordouble positivity to honeybee and yellow jacket venom in patients wi-th stinging-insect allergy. J Allergy Clin Immunol 200 1; 108:1045-52.
47. Ito K, Morishita M, Ohshima M, Sakamoto T, Tanaka A. Cross-reactive carbohydrate determinant contributes to the false positive IgE antibo-dy to peanut. Allergol International 2005;54:387-92.
48. Van Ree A, Aalberse RC. SpeciPc IgE without clinical allergy. J Allergy Clin Immunol 1999;103:1000-1.
49. Steimer W. Performance and speciPcity of monoclonal immunoas-says for cyclosporine monitoring: how speciPc is speciPc? Clin Chem 1999;45:371-81.
50. Lichtebwalner MR, Mencken T, Tully R, Petosa M. False-positive immu-nochemica l screen for methadone attributable to metabolites ofvera-pamil. Clin Chem 1998;44:1039-41.
51. Daher R, HaidarJH, Al-Amin H. Rifampin Interference with Opiate Im-munoassays. Clin Chem 2002;48:203-4.
52. ValdesRJr, JortaniSA. Unexpectedsupressionofimmunoassay results by cross reactivity; now a demonstrated cause for concern. Clin Chem 2002;48:405-6.
53. Ellis MJ, LiveseyJH. Techniques for identifying heterophile antibody in-terference are assay speciPc: study of seven analytes on two automa-ted immunoassay analyzers. Clin Chem 2005; 51:639-41.
54. Choy EH, SchantzA, Pitzalis C, Kingsley GH, Panayi GS. Thepharmaco-kinetics and human anti-mouse antibody response in rheumatoid ar-thritis patients treated with a chimeric anti-CD4 monoclonal antibo-dy. Rheumatology 1998;37:801-2.
55. Reinsberg J, Nocke W. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(a-b')2 fragments of the OC125 antibody. EurJ Clin Chem Clin Biochem 1993;31:323-7.
56. McMillin A, Owen WE, Lambert TL, De BK, Frank EL, Bach PR, et al. Comparable Epects of DIGIBIND and DigiFab in Thirteen Digoxin Im-munoassays. Clinical Chemistry 2002;48:1580-4.
57. Dasgupta A, Reyes MA. Epect of Brazilian, Indian, Siberian, Asian, and North American Ginseng on Serum Digoxin Measurement by Immu-noassays and Binding of Digoxin-like Immunoreactive Components of Ginseng With Fab Fragment. Am J Clin Pathol2005;124:229-36.
58. Ward G, McKinnon L, Badrick T, Hickman PE. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol 1997;108:417-21.
59. Nahm MH, Hopman JW. Heterophile antibody: phantom of the immu-noassay. Clin Chem 1990;36:829.
60. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Act a 2002;325:1-15.
61. Kuroki M, Matsumoto Y, Arakawa F, Haruno M, Murakami M, Kuwa-hara M, et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. J Immunol Met-hods 1995;180:81-91.
62. Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med. 2003;26:133-47.
63. Jeremias A, Gibson CM. Narrative review: Alternative causes for eleva-ted cardiac troponin levels when acute coronary syndromes are exclu-ded. Ann Int Med 2005;142:786-92.
64. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglo-bulin assays. J Clin Endocrinol Metab 2003;88:3069-74.
65. Giovanella L, Ghelfo A. Undetectable serum thyroglobulin due to ne-gative interference of heterophile antibodies in relapsing thyroid car-cinoma. Clin Chem 2007;53:1871-2.
66. Luzzi VI, Scott MG, Gronowski AM. Negative thyrotropin assay in-terference associated with an IgGkappa paraprotein. Clin Chem 2003;49:709-10.
67. Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pet-tersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003;49:1095-104.
68. Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody inter-ference in a multiplexed vuorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 2004;11:325-9.
69. Kellar KL, Kalwar RR, Dubois KA. Multiplexed vuorescent bead-based immunoassays for quantitation of human cytokines in serum and cul-ture supernatants. Cytometry 2001;45:27-36.
70. Banks RE, Measurement of cytokines in clinical samples using immu-noassays: problems and pitfalls. Crit Rev Clin Lab Sci 2000; 37:131-82.
71. Halsall DJ, Mangi M, Soos M, Fahie-Wilson MN, Wark G, Mainwari-ng-Burton R, et al. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-{kappa} myeloma. J Clin Endocrinol Metab 2007;92:2013-6.
72. Zouwail SA, O'Toole AM, Clark PMS, Begley JP. Invuence of Thyroid Hormone Autoantibodies on 7 Thyroid Hormone Assays. Clin Chem 2008;54:927-8.
73. Oei Al, Sweep FC, Massuger LF, OlthaarAJ, Thomas CM. Transient hu-man anti-mouse antibodies (HAMA) interference in CA 125 measure-ments during monitoring of ovarian cancer patients treated with mu-rine monoclonal antibody. Gynecol Oncol 2008;109:199-202.
74. Bertholf RL, Johannsen L, Benrubi G. False elevation of serum CA-125 level caused by human anti-mouse antibodies. Ann Clin Lab Sci 2002;32:414-8.
75. Oldham RK. Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress. J Clin Oncol 2008;26:1774-7.
76. Dodig S, Richter D, Cepelak I, Benko B. Anti-IgE therapy with omalizu-mab in asthma and allergic rhynitis. Acta Pharm 2005;55:123-38.
77. Schulze-Koops H, Lipsky PE. Anti-CD4 Monoclonal Antibody Therapy in Human Autoimmune Diseases. In: Fathman C.G. (ed): Biologic and Gene Therapy of Autoimmune Disease. Curr Dir Autoimmun. Basel, Karger, 2000, vol2, pp 24-49.
78. Reinsberg J. Diperent eccacy of various blocking reagents to elimina-te interferences by human antimouse antibodies with a two-site im-munoassay. Clin Biochem 1996;29:145-8.
79. Butler SA, Cole LA. Use of heterophilic antibody blocking agent (HBT) in reducing false-positive hCG results. Clin Chem 2001;47:1332-3.
80. Bjerner J, Bormer OP, Nustad K. The War on Heterophilic Antibody In-terference. Clin Chem 2005;51:9-11.
81. Warren J, Bjerner J, PausE, Bormer OP, Nustad K. Use of an in vivo bio-tinylated single-chain antibody as capture reagent in an immunomet-ric assay to decrease the incidence of interference from heterophilic antibodies. Clin Chem 2005;51:830-8.
82. Wu JT, Christensen SE. Epect of diperent test designs of immunoas-says on "hook epect" of CA 19-9 measurement. J Clin Lab Anal 1991;5: 228-32.
83. Unnikrishnan AG, Rajaratnam S, Seshadri MS, Kanagasapabathy AS, Stephen DC. The 'hook epect' on serum prolactin estimation in a pa-tient with macroprolactinoma. Neurol India 2001;49:78-80.
84. Amarasiri FS, Wilson GS. Studies of the 'hook' epect in the one-step sandwich immunoassay. J Immunol Methods 1992;151:47-66.
85. Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J. "Hook epe-ct" in complete hydatidiform molar pregnancy: a falsely low level ofβ-HCG. ObstetGynecol 1993;82:720-1.
86. Van Lente F. Light scattering immunoassays. Rose NR de Macario EC Folds JD Lane HC Nakamura RM eds. Manual of clinical laboratory im-munology, 5th ed 1997:13-19 ASM Press Washington.
87. Jury DR, Mikkelsen DJ, Dunn PJ. Prozone epect and the turbidimetric measurement of albumin in urine. Clin Chem 1990;36:1518-9.
88. Killeen AA, Ramey ML, Dean JJ. High-dose hook epect in an immuno-luminometric thyrotropin assay: the open-faced sandwich artefact. Ann Clin Biochem 1993;30:413-4.
89. CharrieA, Charriere G, GuerrierA. Hookepectin immunometricassays for prostate-speciPc antigen. Clin Chem 1995;41:480-1.
90. Fernando SA, Wilson GS. Studies of the 'hook' epect in the one-step sandwich immunoassay. J Immunol Methods 1992;151:47-66.
91. Cole TG, Johnson D, Eveland BJ, Nahm MH. Cost-epective method for detection of "hook epect" in tumor marker immuometric assays. Clin Chem 1993;39:695-6.
92. Wood GW. "Matrix epect" in immunoassay. Scand J Clin Lab Invest 1991;51;105-12.
93. Yoshida H, Imafuku Y, Nagai T. Matrix epects in clinical immunoas-says and the epect of preheating and cooling analytical samples. Clin Chem Lab Med2004;42:51-6.
94. Feng-Bo Wu, You-Feng He, Shi-Quan Han. Matrix interference in se-rum total thyroxin (T4) time-resolved vuorescence immunoassay (TR-FIA) and its elimination with the use ofstreptavidin-biotin separation technique. Clin Chim Acta 2001;308:117-26.
95. Gerhardt W, Nordin G, Herbert AK, Burzell BL, Isaksson A, Gustavsson E, et al. Troponin Tand I assays show decreased concentrations in he-parin plasma compared with serum: lower recoveries in early than in late phases ofmyocardial injury. Clin Chem 2000;46:817-21.
96. Katrukha AG, Bereznikova AV, Esakova TV, Petterson K, Lövgen T, Se-verina ME, et al. Troponin I is released in bloodstream of patients wi-th myocardial infarction not in free form but as a complex. Clin Chem 1997;43:1379-85.
97. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Foller L. Heparin: mechanism of action, pharmacokinetics, dosing, considerations, mo-nitoring, eccacy, and safety. Chest 1995;108(Suppl4):258-75.
98. Wu AHB, Fen YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum af-ter acute myocardial infarction and comparison of assays for troponin Tand I. Clin Chem 1998;44:1198-208.
99. Wu HB, Apple FS, Gibler BW, Jesse RL, Warshaw MM, Valdes R. Natio-nal Academy of Clinical Biochemistry Standards of Laboratory Practi-ce: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
100. Karppi J, Akerman KK, Parviainen M. Suitability of collection tubes wi-th separator gels for collecting and storing blood samples for thera-peutic drug monitoring (TDM).Clin Chem Lab Med2000;38:313-20.
101. Rosa-Fraile M, Sampedro A, Rodriguez-Granger J, Camacho E, Man-rique E. Suitability of Frozen Serum Stored in Gel Separator Prima-ry Sampling Tubes for Serological Testing. Clin Diagn Lab Immunol 2004;11:219-21.
102. Rej R, Drake P. The nature of calibrators in immunoassays: are they commutable with test samples? Must they be? Scand J Clin Lab Inve-st Suppl 1991;205:47-54.
103. Gaines-Das RE, Brettschneider H, Bristow AF. The epects of common matrices for assay standards on performance of'ultra sensitive' immu-nometric assays for TSH. Report of a joint WHO/IFCC collaborative stu-dy. Clin Chim Acta 1991 ;16:203:5-15.
104. Hubl W, Zogbaum M, BOydJC, Savory J, Schubert M, Meyer D, Derma-nt T. Evaluation of analytical methods and workvow performance of the Architect ci8200 integrated serum/plasma analyzer system. Clin Chim Acta 2005;357:43-54.
105. Esfandiari N, Goldberg JM. Heterophile antibody blocking agent to conPrm false positive serum human chorionic gonadotropin assay. ObstetGynecol 2003;101:1144-6.
106. Norden AG, Jackson RA, Norden LE, Gricn AJ, Barnes MA, Little JA. Mis-leading results from immunoassays of serum free thyroxine in the pre-sence of rheumatoid factor. Clin. Chem 1997;43:957-62.
107. Fitzmaurice TF, Brown C, Rifai N, Wu AHB, Yeo K-TJ. False increa-se of cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:2212-4.
108. Morrisey NE, Quadri SF, Kinders R, Brig ham C, Rose S, Blend MJ. Modi-Ped method for determining carcinoembryonic antigen in the presen-ce of human anti-murine antibodies. Clin Chem 1993;39:522-9.
109. Preissner CM, Dodge LA, O'Kane DJ, Singh RJ, Grebe SKG. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem 2005; 51:208-10.
110. Ismail AA, WAlker PL, CawoodML, BarthJH; Interference in immunoas-say is an underestimated problem. Ann Clin Biochem 2002;39:366-73.
111. White GH, Tideman PA. Heterophilic antibody interference with CAR-DIAC T quantitative rapid assay. Clin Chem 2002;48:201-3.